2nd Quarter - Report

TCH GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S.Con.Res.11-An original concurrent resolution setting forth the congressional budget for the United States government for fiscal year 2016.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 11 (114th)

Health Issues HCR

General heath care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative regulatory issues. 340B Drug Discount Program

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (114th)

Medicare/Medicaid MMM

Medicare Part D issues. S.31 Medicare Prescription Drug Price Negotiation Act- Provisions related to Part D program. S.141 Protecting Seniors Access to Medicare Act of 2015. H.R. 1470 SGR Repeal and Medicare Provider Payment Modernization Act of 2015.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 31 (114th), H.R. 1470 (114th), S. 141 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.